Agilent Technologies Inc at SVB Leerink Global Healthcare Conference (Virtual) Transcript
All right. Great. Welcome, everyone. I'm Puneet Souda, SVB Leerink's tools and diagnostic analyst here. And it's my pleasure to have Agilent management team's CFO, Bob McMahon, joining us; and Head of Investor Relations, Ankur Dhingra, also joining us.
Welcome, guys. Glad to have you at our conference.
Thanks, Puneet. And it certainly is a pleasure to talk to you and have an opportunity to talk about Agilent.
We posted a strong start to the year, and I'm sure we'll get into it, with revenues of a little over $1.5 billion, with 14% reported growth and 11% core. And the great news about that was it was really broad-based across all 3 of our business groups. All 3 of our business groups grew double digits. And that strong top line translated into 31% earnings per share growth for the quarter. And as a result of the strong quarter and the solid momentum that
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |